Загрузка...
A Randomized Pilot Study of Donor Stem Cell Infusion in Living-Related Kidney Transplant Recipients Receiving Alemtuzumab
BACKGROUND: Transplant tolerance would remove the need for maintenance immunosuppression while improving survival and quality of life. METHODS: A prospective, randomized pilot study was undertaken to assess the safety and efficacy of donor stem cell infusion (DSCI) in living-related kidney transplan...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
2013
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3818358/ https://ncbi.nlm.nih.gov/pubmed/23903014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e3182a0f68c |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|